SCHEMBL1728610

SCHEMBL1728610

CN(CCOc1ccc(-n2ccn(-c3ccc(Oc4ccccc4)cc3)c2=O)cc1)CCc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.57
MCHR1 Q99705 4/20 0.53
LTA4H P09960 3/20 0.49
CACNA1F O60840 1/20 0.45
CHRM2 P08172 1/20 0.45
ACHE P22303 1/20 0.45
AGTR1 P30556 1/20 0.45
DRD3 P35462 1/20 0.45
CACNA1D Q01668 1/20 0.45
CACNA1S Q13698 1/20 0.45
CACNA1C Q13936 1/20 0.45
TSHR P16473 1/20 0.44
NPY5R Q15761 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1728748 0.90 MCHR1 (0.66) KCNH2MCHR1LTA4HACHETSHR
SCHEMBL1728135 0.88 LTA4H (0.51) KCNH2MCHR1LTA4HTSHR
SCHEMBL6081348 0.88 LTA4H (0.51) KCNH2MCHR1LTA4HTSHR
SCHEMBL1728641 0.86 GNRHR (0.48) KCNH2MCHR1LTA4HTSHR
SCHEMBL1728669 0.86 LTA4H (0.68) KCNH2MCHR1LTA4H
SCHEMBL1728663 0.82 LTA4H (0.44) KCNH2MCHR1LTA4H
SCHEMBL1728580 0.81 LTA4H (0.51) KCNH2MCHR1LTA4H
SCHEMBL1729935 0.81 MCHR1 (0.45) KCNH2MCHR1LTA4H
SCHEMBL4775058 0.80 KCNH2 (0.79) KCNH2LTA4HCACNA1FCHRM2ACHE
SCHEMBL1729079 0.79 GAA (0.62) KCNH2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551810-B1 DIARYL-SUBSTITUTED CYCLIC UREA DERIVATIVES HAVING AN MCH-MODULATORY EFFECT SANOFI AVENTIS DEUTSCHLAND (DE) 2011-11-30 EP disclosed
US-7141561-B2 Substituted diaryl heterocycles, process for their preparation and their use as medicaments SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-11-28 US disclosed